Treatment Options


Understanding Your Pathology Report: Colon Cancer
Your pathology report provides important information about your tumor and is something you should keep in your personal files.
Stage II Colon Cancer: To Treat or Not to Treat?
You would think that deciding whether to have chemotherapy after surgery (adjuvant therapy) in stage II colon cancer would be an easy decision, but in fact, studies have not found a clear answer to this question.
OncoLink Meet the Professor: Weijing Sun, MD discusses developments in colon cancer therapy
A new monoclonal antibody is approved for the treatment of advanced colon cancer
Another coup for targeted therapy
Eloxatin approved for first line treatment of advanced colorectal cancer

News
Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.



I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More